SUN GENOMICS
Joliet, US · Founded 2016 · 9 employees on LinkedIn · 2 known investors
Find your way into SUN GENOMICS
267 people in our graph share verified history with the SUN GENOMICS team — schools, employers, funds. One of them is your warm intro.
René Kuijtenunlockedknows Craig Rouskey · together at Academic Medical Center (AMC) (overlapped)
×2knows the team · via Life Technologies
knows the team · via SUN GENOMICS
×4knows the team · via University of Iowa
×3knows the team · via Southern Illinois University, Carbondale
knows the team · via Saint Louis University
Flore creates personalized probiotics based on individual microbiome sequencing, analyzing gut health markers to formulate targeted probiotic blends for each customer. The company serves consumers seeking customized solutions for digestive and gut-brain health issues.
Founders & leadership
SUN GENOMICS was founded in 2016 by Suneer Jain.
SJ
Suneer JaininCEO and FounderSuneer Jain brings 30 years of experience in molecular and microbiology, with 20 years in laboratory and operations management, including a decade in executive roles. His background spans P&L management, clinical R&D, clinical trials, assay development, and regulatory compliance across CLIA, CAP, and GLP standards.
CR
Craig RouskeyinCEOHe brings over 20 years of experience in molecular biology, immunology, and medical microbiology, previously serving as co-founder and CEO of renegade.bio, a precision diagnostics company.
MC
Megan CrockerinCOO, Flore Inc.Megan Crocker is Chief Operating Officer and Compliance Officer at Flore Inc., a company developing personalized probiotics based on individual microbiome sequencing. She focuses on building operational processes, quality management systems, and standard operating procedures to support the company's growth and regulatory compliance.
RS
Randy SocolExecutive
Investors · 2
Reported raises · per SEC filings
Form D private placements$3.6M disclosed across 2 rounds · 2018
▶$3MraisedJan 2019 · 20 investors · BiotechnologyRule 506(b)
▶$3MraisedJan 2019 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Randy SocolExecutive Officer
- Suneer JainExecutive Officer, Director
- Offering amount
- $3.8M
- Amount sold
- $3M
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$625KraisedSep 2018 · 9 investors · BiotechnologyRule 506(b)
▶$625KraisedSep 2018 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Randy SocolExecutive Officer
- Suneer JainExecutive Officer, Director
- Offering amount
- $625K
- Amount sold
- $625K
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does SUN GENOMICS do?
- Flore creates personalized probiotics based on individual microbiome sequencing, analyzing gut health markers to formulate targeted probiotic blends for each customer. The company serves consumers seeking customized solutions for digestive and gut-brain health issues.
- Who founded SUN GENOMICS?
- SUN GENOMICS was founded by Suneer Jain in 2016.
- Who are SUN GENOMICS's investors?
- SUN GENOMICS's investors include Danone Manifesto Venture, Pangaea Ventures Us Inc..
- How much funding has SUN GENOMICS raised?
- SUN GENOMICS has disclosed $3.6M raised across 2 rounds.
- Where is SUN GENOMICS headquartered?
- SUN GENOMICS is headquartered in Joliet, US.